Company intelligence / Profile preview

Trio Healthcare International

United Kingdom

Ownership: Private
Development stage: Other

Overview

Trio Healthcare International was a UK-based company specializing in innovative ostomy care accessory products featuring advanced silicone technologies. The company developed and marketed several key products including Niltac™ sting free medical adhesive remover, Silesse™ sting free skin barrier, and Diamonds™ Gelling Sachets with ActiveOne™ odor control. Products were available in more than 20 countries prior to acquisition.

Therapeutic areas: OtherDermatologyGastroenterology
Modalities: Device
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on Trio Healthcare International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trio Healthcare International.

Explore the full profile